As a service provider, we leverage cutting-edge 3D bioprinting technologies such as the Cellink BioX6, CellINK BioOne and Rastrum to create highly detailed, biologically relevant tissue models for drug discovery and disease modeling. Our platforms enable embedded structure printing in advanced matrices like Matrigel, hydrogel, alginate, collagen and custom 3D scaffolds, ensuring accurate tissue architecture and cell behavior. Additionally, we utilise droplet-based robotic systems such as the JANUS and Multidrop to support high-throughput applications, including Matrigel-based and matrix-free environments like spheroid plates, offering flexibility for various applications and assay needs. This comprehensive suite of technologies enhances preclinical testing, helping to accelerate drug development and improve the predictive power of disease models.